BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38394468)

  • 1. Pan-Cancer Interrogation of
    Paller CJ; Tukachinsky H; Maertens A; Decker B; Sampson JR; Cheadle JP; Antonarakis ES
    JCO Precis Oncol; 2024 Feb; 8():e2300251. PubMed ID: 38394468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Base excision repair deficiency signatures implicate germline and somatic
    Thibodeau ML; Zhao EY; Reisle C; Ch'ng C; Wong HL; Shen Y; Jones MR; Lim HJ; Young S; Cremin C; Pleasance E; Zhang W; Holt R; Eirew P; Karasinska J; Kalloger SE; Taylor G; Majounie E; Bonakdar M; Zong Z; Bleile D; Chiu R; Birol I; Gelmon K; Lohrisch C; Mungall KL; Mungall AJ; Moore R; Ma YP; Fok A; Yip S; Karsan A; Huntsman D; Schaeffer DF; Laskin J; Marra MA; Renouf DJ; Jones SJM; Schrader KA
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30833417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis.
    Barreiro RAS; Sabbaga J; Rossi BM; Achatz MIW; Bettoni F; Camargo AA; Asprino PF; A F Galante P
    J Pathol; 2022 Feb; 256(2):214-222. PubMed ID: 34816434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUTYH-associated tumor syndrome: The other face of MAP.
    Magrin L; Fanale D; Brando C; Corsini LR; Randazzo U; Di Piazza M; Gurrera V; Pedone E; Bazan Russo TD; Vieni S; Pantuso G; Russo A; Bazan V
    Oncogene; 2022 Apr; 41(18):2531-2539. PubMed ID: 35422474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures.
    Georgeson P; Harrison TA; Pope BJ; Zaidi SH; Qu C; Steinfelder RS; Lin Y; Joo JE; Mahmood K; Clendenning M; Walker R; Amitay EL; Berndt SI; Brenner H; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Doheny KF; Drew DA; Figueiredo JC; French AJ; Gallinger S; Giannakis M; Giles GG; Gsur A; Gunter MJ; Hoffmeister M; Hsu L; Huang WY; Limburg P; Manson JE; Moreno V; Nassir R; Nowak JA; Obón-Santacana M; Ogino S; Phipps AI; Potter JD; Schoen RE; Sun W; Toland AE; Trinh QM; Ugai T; Macrae FA; Rosty C; Hudson TJ; Jenkins MA; Thibodeau SN; Winship IM; Peters U; Buchanan DD
    Nat Commun; 2022 Jun; 13(1):3254. PubMed ID: 35668106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.
    Pilati C; Shinde J; Alexandrov LB; Assié G; André T; Hélias-Rodzewicz Z; Ducoudray R; Le Corre D; Zucman-Rossi J; Emile JF; Bertherat J; Letouzé E; Laurent-Puig P
    J Pathol; 2017 May; 242(1):10-15. PubMed ID: 28127763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
    Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
    Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of the common germline MUTYH mutations p.G396D and p.Y179C in patients diagnosed with colorectal cancer in Southern Brazil.
    Pitroski CE; Cossio SL; Koehler-Santos P; Graudenz M; Prolla JC; Ashton-Prolla P
    Int J Colorectal Dis; 2011 Jul; 26(7):841-6. PubMed ID: 21424714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUTYH hotspot mutations in unselected colonoscopy patients.
    Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
    Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c.1227_1228dupGG (p.Glu410Glyfs), a frequent variant in Tunisian patients with MUTYH associated polyposis.
    Kdissa A; Brusgaard K; Ksiaa M; Golli L; Hallara O; Ousager LB; Manoubi W; Seghaier RB; Adala L; Halleb Y; Saad A; Hmila F; Gribaa M
    Cancer Genet; 2020 Jan; 240():45-53. PubMed ID: 31739127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells.
    Robinson PS; Thomas LE; Abascal F; Jung H; Harvey LMR; West HD; Olafsson S; Lee BCH; Coorens THH; Lee-Six H; Butlin L; Lander N; Truscott R; Sanders MA; Lensing SV; Buczacki SJA; Ten Hoopen R; Coleman N; Brunton-Sim R; Rushbrook S; Saeb-Parsy K; Lalloo F; Campbell PJ; Martincorena I; Sampson JR; Stratton MR
    Nat Commun; 2022 Jul; 13(1):3949. PubMed ID: 35803914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?
    Weren RD; Ligtenberg MJ; Geurts van Kessel A; De Voer RM; Hoogerbrugge N; Kuiper RP
    J Pathol; 2018 Feb; 244(2):135-142. PubMed ID: 29105096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic Cohorts.
    Downie JM; Riaz M; Xie J; Lee M; Chan AT; Gibbs P; Orchard SG; Mahady SE; Sebra RP; Murray AM; Macrae F; Schadt E; Woods RL; McNeil JJ; Lacaze P; Gala M
    Cancer Prev Res (Phila); 2022 Aug; 15(8):509-519. PubMed ID: 35609203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer.
    Viel A; Bruselles A; Meccia E; Fornasarig M; Quaia M; Canzonieri V; Policicchio E; Urso ED; Agostini M; Genuardi M; Lucci-Cordisco E; Venesio T; Martayan A; Diodoro MG; Sanchez-Mete L; Stigliano V; Mazzei F; Grasso F; Giuliani A; Baiocchi M; Maestro R; Giannini G; Tartaglia M; Alexandrov LB; Bignami M
    EBioMedicine; 2017 Jun; 20():39-49. PubMed ID: 28551381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.
    van Puijenbroek M; Nielsen M; Reinards TH; Weiss MM; Wagner A; Hendriks YM; Vasen HF; Tops CM; Wijnen J; van Wezel T; Hes FJ; Morreau H
    Fam Cancer; 2007; 6(1):43-51. PubMed ID: 17039270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the base excision repair gene MUTYH in sporadic colorectal cancer.
    Kuno T; Matsubara N; Tsuda S; Kobayashi M; Hamanaka M; Yamagishi D; Tsukamoto K; Yamano T; Noda M; Ikeuchi H; Kim S; Tamura K; Tomita N
    Oncol Rep; 2012 Aug; 28(2):473-80. PubMed ID: 22641385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of inherited defects of MYH in the development of sporadic colorectal cancer.
    Kambara T; Whitehall VL; Spring KJ; Barker MA; Arnold S; Wynter CV; Matsubara N; Tanaka N; Young JP; Leggett BA; Jass JR
    Genes Chromosomes Cancer; 2004 May; 40(1):1-9. PubMed ID: 15034862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First evidence for digenic inheritance in hereditary colorectal cancer by mutations in the base excision repair genes.
    Morak M; Massdorf T; Sykora H; Kerscher M; Holinski-Feder E
    Eur J Cancer; 2011 May; 47(7):1046-55. PubMed ID: 21195604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplifying the detection of MUTYH mutations by high resolution melting analysis.
    López-Villar I; Ayala R; Wesselink J; Morillas JD; López E; Marín JC; Díaz-Tasende J; González S; Robles L; Martínez-López J
    BMC Cancer; 2010 Aug; 10():408. PubMed ID: 20687945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.